BMY vs REVG · P/E 17, rev $24.46B vs P/E 34, rev $2.38B
Bristol-Myers Squibb Company (BMY) versus Rev Group Inc (REVG) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Rev Group Inc (REVG) is a farm & heavy construction machinery company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported REVG revenue for 2024-10-31 was $2.38B. Net income was $257.6M. Revenue was down 9.8% from 2023-10-31 to 2024-10-31. REVG currently screens at market cap $3.12B and trailing P/E 33.8.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. REVG currently screens at market cap $3.12B and trailing P/E 33.8.
Not investment advice. Open the BMY and REVG stock pages for the full models.
Not investment advice.